In pathological situations such as cerebral ischemia, excessive increases in vascular permeability lead to opening of the blood brain barrier (BBB) and vasogenic edema, which is a major cause of death in acute stroke patients. Any therapeutic strategy aimed at attenuating the disruption of the BBB and therefore the severity of vasogenic edema will have a significant impact in the mortality of patients with ischemic stroke. Tissue-type plasminogen activator (tPA) is predominantly found in the blood where its primary function is as a thrombolytic enzyme. tPA is also expressed within the central nervous system (CNS) where it is thought to have a different function. In ischemic stroke, endogenous tPA activity increases within the ischemic hemisphere and either genetic deficiency or pharmacological inhibition of tPA have been associated with decrease in infarct volume. Preliminary studies demonstrate that both endogenous tPA released from intracellular stores in response to the ischemic insult and exogenous tPA administered as a thrombolytic therapy for embolic stroke, directly cause disruption of the BBB. Since tPA is the only FDA-approved medication for the treatment of patients with acute stroke, it is of vital importance to establish whether this proteinase has a deleterious effect on the BBB during cerebral ischemia. Accordingly, this application will focus on understanding the role of tPA as a regulator of cerebrovascular permeability during cerebral ischemia. By using a combination of biochemical, molecular, pharmacological and genetic approaches, both in vitro and in vivo, and building on previous studies of the effect of tPA and the Lipoprotein Receptor Related Protein (LRP) on cerebrovascular permeability, we will test the following hypotheses: 1) following the onset of cerebral ischemia there is an early increase in the release of tPA, possibly from the glial cells; 2) the association of this tPA with LRP in the BBB induces a specific cell signaling event, likely through phosphorylation of a member of the Mitogen-Activated Protein Kinase (MAPK) family; and 3) MAPK phosphorylation results in changes in cytoskeletal and tight junction (TJ) proteins with subsequent increases in cerebrovascular permeability. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS049478-02
Application #
7105059
Study Section
Special Emphasis Panel (ZRG1-CDIN (01))
Program Officer
Jacobs, Tom P
Project Start
2005-08-02
Project End
2009-05-31
Budget Start
2006-06-01
Budget End
2007-05-31
Support Year
2
Fiscal Year
2006
Total Cost
$310,948
Indirect Cost
Name
Emory University
Department
Neurology
Type
Schools of Medicine
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Chan, Chi Bun; Liu, Xia; Pradoldej, Sompol et al. (2011) Phosphoinositide 3-kinase enhancer regulates neuronal dendritogenesis and survival in neocortex. J Neurosci 31:8083-92
Ranganathan, Sripriya; Noyes, Nathaniel C; Migliorini, Mary et al. (2011) LRAD3, a novel low-density lipoprotein receptor family member that modulates amyloid precursor protein trafficking. J Neurosci 31:10836-46
Zhang, Chen; An, Jie; Haile, Woldeab B et al. (2009) Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain. J Cereb Blood Flow Metab 29:1946-54
Roussel, Benoit D; Macrez, Richard; Jullienne, Amandine et al. (2009) Age and albumin D site-binding protein control tissue plasminogen activator levels: neurotoxic impact. Brain 132:2219-30
Zhang, Chen; An, Jie; Strickland, Dudley K et al. (2009) The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain. Am J Pathol 174:586-94
Liu, Zhixue; Jang, Sung-Wuk; Liu, Xia et al. (2008) Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase. Mol Cell 29:665-78
Mannaioni, Guido; Orr, Anna G; Hamill, Cecily E et al. (2008) Plasmin potentiates synaptic N-methyl-D-aspartate receptor function in hippocampal neurons through activation of protease-activated receptor-1. J Biol Chem 283:20600-11
Polavarapu, Rohini; An, Jie; Zhang, Chen et al. (2008) Regulated intramembrane proteolysis of the low-density lipoprotein receptor-related protein mediates ischemic cell death. Am J Pathol 172:1355-62
Su, Enming J; Fredriksson, Linda; Geyer, Melissa et al. (2008) Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 14:731-7
An, Jie; Zhang, Chen; Polavarapu, Rohini et al. (2008) Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain. Blood 112:2787-94

Showing the most recent 10 out of 17 publications